Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

LaValle Healthcare awaiting DSHEA clarification before launching into supplement trade.

This article was originally published in The Tan Sheet

Executive Summary

LAVALLE HEALTHCARE AWAITING DIETARY SUPPLEMENT LAW CLARIFICATION before marketing herbal or nutritional supplements, the homeo-pathic treatments firm said. The company has considered entering the marketplace with an herbal or nutritional supplement, but decided to avoid the complications of trying to make claims for the products until the Dietary Supplement Health & Education Act governing the products is further clarified, the company said, claiming "homeopaths want regulation" of products.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086270

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel